These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R. Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [Abstract] [Full Text] [Related]
3. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study. Sigurdsson V, Toonstra J, Bihari IC, Bruijnzeel-Koomen CA, van Vloten WA, Thepen T. J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812 [Abstract] [Full Text] [Related]
4. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A. Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128 [Abstract] [Full Text] [Related]
5. T cells involved in psoriasis vulgaris belong to the Th1 subset. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde KH, Fleischer B. J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745 [Abstract] [Full Text] [Related]
6. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. Asadullah K, Döcke WD, Haeussler A, Sterry W, Volk HD. J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670 [Abstract] [Full Text] [Related]
7. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P. J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579 [Abstract] [Full Text] [Related]
8. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions. Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic M. Arch Dermatol Res; 2006 Dec; 298(7):353-6. PubMed ID: 17021762 [Abstract] [Full Text] [Related]
13. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ. Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [Abstract] [Full Text] [Related]
14. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Cirée A, Michel L, Camilleri-Bröet S, Jean Louis F, Oster M, Flageul B, Senet P, Fossiez F, Fridman WH, Bachelez H, Tartour E. Int J Cancer; 2004 Oct 20; 112(1):113-20. PubMed ID: 15305382 [Abstract] [Full Text] [Related]
19. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Nguyen GH, Olson LC, Magro CM. Ann Diagn Pathol; 2017 Jun 20; 28():54-59. PubMed ID: 28648940 [Abstract] [Full Text] [Related]
20. TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. Ponti R, Fierro MT, Quaglino P, Lisa B, Paola Fd, Michela O, Paolo F, Comessatti A, Novelli M, Bernengo MG. J Invest Dermatol; 2008 Apr 20; 128(4):1030-8. PubMed ID: 17989737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]